Ā | Number | % |
---|---|---|
Sex | Ā | Ā |
āāMale | 63 | 64.9 |
āāFemale | 34 | 35.1 |
Age, meanāĀ±āSD | 66.9āĀ±ā9.0 | Ā |
Histology | Ā | Ā |
āāAdenocarcinoma | 65 | 67.0 |
āāSquamous cell carcinoma | 17 | 17.5 |
āāLarge cell carcinoma | 8 | 8.2 |
āāAdenosquamous carcinoma | 2 | 2.1 |
āāPleomorphic carcinoma | 5 | 5.2 |
Tumor differentiation | Ā | Ā |
āāWell | 29 | 29.9 |
āāModerate | 29 | 29.9 |
āāPoor | 39 | 40.2 |
Nodal status | Ā | Ā |
āāN0 | 56 | 57.7 |
āāN1 | 19 | 19.6 |
āāN2 | 22 | 22.7 |
Pathological stage | Ā | Ā |
āāIA | 10 | 10.3 |
āāIB | 32 | 33.0 |
āāIIAā+āIIB | 27 | 27.8 |
āāIIIA | 28 | 28.9 |
Chemotherapy regimen | Ā | Ā |
āPlatinum-based agent | 51 | 52.6 |
āāCBDCAā+āpaclitaxel | 35 | Ā |
āāCBDCAā+āgemcitabine | 7 | Ā |
āāCBDCAā+āS1 | 5 | Ā |
āāCDDPā+āothers | 4 | Ā |
āOral tegafur agent | 46 | 47.4 |
āāUFT | 37 | Ā |
āāS1 | 9 | Ā |